Valuation : Dr. Reddy's Laboratories Limited

Market Cap 979B 10.25B 8.8B 8.24B 7.54B 14.21B 14.25B 97.52B 38.12B 493B 38.48B 37.64B 1,633B P/E 2027 *
26x
P/E 2028 * 20.1x
Enterprise Value 947B 9.92B 8.51B 7.97B 7.3B 13.75B 13.79B 94.38B 36.89B 477B 37.23B 36.43B 1,580B EV / Sales 2027 *
2.69x
EV / Sales 2028 * 2.36x
Free-Float
69.71%
Yield 2027 *
0.65%
Yield 2028 * 0.72%
1 day-0.96%
1 week+0.34%
Current month+2.39%
1 month+2.09%
3 months-11.61%
6 months-10.91%
Current year-7.56%
1 week 1,168.8
Extreme 1168.8
1,194.5
1 month 1,130.6
Extreme 1130.6
1,207.9
Current year 1,080.05
Extreme 1080.05
1,414.4
1 year 1,080.05
Extreme 1080.05
1,414.4
3 years 1,025.9
Extreme 1025.9
1,420.2
5 years 731
Extreme 731
1,420.2
10 years 377.6
Extreme 377.6
1,420.2
Manager TitleAgeSince
Chief Executive Officer 59 01/07/2019
Director of Finance/CFO - 01/08/2024
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 13/05/2014
Chairman 65 02/04/2013
Director/Board Member 65 25/10/2018
Date Insider Type Main position Quantity % Market Cap.
12/18/25 A Other

Chairman

85,738,125 10.2732%
12/18/25 A Other

Director

12,717,090 1.5238%
12/18/25 A Other

Director

27,618,385 3.3092%
Change 5-day change 1-year change 3-year change Capi.($)
-0.96%+0.34%-6.99%+1.60% 10.36B
-1.12%-5.49%+60.19%+112.43% 1,060B
-1.57%-0.60%+50.33%+59.86% 651B
-1.81%-1.41%+24.07%+75.98% 465B
-1.17%-2.10%+38.61%+40.43% 365B
-2.00%-1.35%+22.22%+38.92% 300B
-0.98%+0.53%+2.04%+12.13% 258B
-0.76%+0.75%+51.75%+70.45% 238B
-3.18%-0.30%-17.23%-53.79% 210B
+0.52%+3.78%+30.67%+93.68% 184B
Average -1.30%+0.07%+25.57%+45.17% 374.08B
Weighted average by Cap. -1.36%-1.45%+38.31%+65.68%

Financials

2027 *2028 *
Net sales 352B 3.68B 3.16B 2.96B 2.71B 5.11B 5.12B 35.06B 13.71B 177B 13.83B 13.54B 587B 393B 4.11B 3.53B 3.31B 3.03B 5.7B 5.72B 39.14B 15.3B 198B 15.44B 15.11B 655B
Net income 37.22B 390M 335M 313M 287M 540M 542M 3.71B 1.45B 18.76B 1.46B 1.43B 62.08B 48.99B 513M 440M 412M 377M 711M 713M 4.88B 1.91B 24.69B 1.93B 1.88B 81.71B
Net Debt -31.58B -331M -284M -266M -243M -458M -460M -3.15B -1.23B -15.92B -1.24B -1.21B -52.68B -51.62B -540M -464M -434M -398M -749M -751M -5.14B -2.01B -26.02B -2.03B -1.99B -86.1B
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,527
Date Price Change Volume
27/08/26 ₹1,175.00 -0.96% 705,737
26/08/26 ₹1,186.40 -0.39% 40,064
25/08/26 ₹1,191.00 -0.29% 39,623
24/08/26 ₹1,194.50 +1.66% 54,869
21/08/26 ₹1,175.00 -0.54% 28,730
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
39
Last Close Price
1,175.00INR
Average target price
1,265.77INR
Spread / Average Target
+7.73%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 500124 Stock